HLHui Li

Hui Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hui Li has a total of 125 co-authors. Here are the top co-authors by number of shared publications:

  • Tao Xiao

    Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China

    14 shared publications
  • Bo Xiao

    Department of Orthopedics, The Second Xiangya Hospital of Central South University, Changsha, China

    11 shared publications
  • Cheng Xiang

    Department of Orthopedics, The Second Xiangya Hospital of Central South University, Changsha, China

    10 shared publications
  • Pingxiao Wang

    Department of Orthopedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

    10 shared publications
  • Yu Xia

    Department of Orthopedics, The Second Xiangya Hospital of Central South University, Changsha, People’s Republic of China

    9 shared publications
  • Aoyu Li

    Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China

    8 shared publications

Latest Publications

  • Associations of cardiovascular health and genetic susceptibility with incident psoriatic arthritis: findings from two cohort studies

    by Pan Li, Xianggang Wang, Boqing Tang, Peng Gu, Guanyi Chen, Xinzhan Mao, Tao Xiao, Hui Li

    Introduction Psoriatic arthritis (PsA), a chronic inflammatory disease associated with psoriasis, may be influenced by cardiovascular health (CVH). This study aims to investigate the associations between three CVH scores (Life’s Simple 7 (LS7), Life’s Essential 8 (LE8), and Life’s Crucial 9 (LC9)) and a psychological health (PH) score with PsA risk and potential interactions with genetic susceptibility. Methods Using data from the UK Biobank and NHANES cohorts, we conducted prospective and cross-sectional analyses employing Cox proportional hazards and multivariable logistic regression models, respectively. Additionally, a polygenic risk score (PRS) was derived in the UK Biobank to quantify genetic susceptibility to PsA and examine its interactions with CVH and PH metrics. Results Higher scores in LE8, LC9, and PH showed consistent inverse associations with PsA, with the most pronounced association observed for LC9. Higher LC9 scores showed a strong inverse association with PsA (highest vs lowest group: OR = 0.25 (95% CI 0.05, 0.86), HR = 0.20 (95% CI 0.06, 0.65)). Each 10-point LC9 increase corresponded to lower PsA risk (OR = 0.76 (95% CI 0.58, 0.98), HR = 0.68 (95% CI 0.54, 0.86)). Genetic risk (assessed as the inverse of the PRS) showed significant antagonistic interactions with LE8, LC9, and PH scores. Conclusion Inverse associations were observed between LE8, LC9, and PH scores and PsA risk, along with notable interactions with genetic predisposition. Key Points • Higher LE8, LC9, and PH scores showed inverse associations with PsA. • LC9 showed the strongest inverse association with PsA in both cohorts. • Genetic susceptibility showed antagonistic interactions with LE8, LC9 and PH scores.

  • Construction of growth plate organoids via a layered induction based in vitro 3D cultivation system

    by Xianggang Wang, Pan Li, Mohammad Nour Muselmani, Peng Gu, Xinzhan Mao, Tao Xiao, Hui Li


  • Open Access

    Association between lipid metabolites and progression to joint arthroplasty in hip/knee osteoarthritis: a prospective cohort study

    by Xianggang Wang, Pingxiao Wang, Peng Msc Gu, Guanyi Chen, Xinzhan Mao, Tao Xiao, Hui Li

    Background: Hip or knee osteoarthritis (OA) frequently culminates in joint arthroplasty, yet reliable biomarkers to predict this progression are lacking. We aimed to investigate whether baseline levels of seven serum lipid metabolites are associated with the risk and timing of subsequent joint replacement among participants diagnosed with hip or knee OA. Methods: Leveraging prospective data from the UK Biobank, we identified 56 978 participants newly diagnosed with hip or knee OA after the baseline measurement of seven serum lipid markers. We applied Fine & Gray competing risk models to estimate the impact of lipid indices on time to arthroplasty, complemented by accelerated failure time (AFT) modeling, threshold-effect analysis, subgroup stratification, and polygenic risk score (PRS) assessment to comprehensively characterize associations between lipid metabolites and OA progression. Results: Both Fine & Gray competing risk and AFT analyses consistently demonstrated that elevated total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein A1 (ApoA1), and apolipoprotein B (ApoB) levels were significantly associated with increased risk of joint replacement and accelerated disease course ( P < 0.001). Lipoprotein(a) and triglycerides (TG) showed no significant relationship. Threshold analyses revealed inflection points beyond which risk increases plateaued. Findings remained robust in multiple-imputation and alternative model sensitivity analyses. Subgroup analyses indicated that participants younger than 60 years, those with hip site osteoarthritis, and especially obese women with high genetic risk exhibited heightened sensitivity to lipid fluctuations, underscoring the need for tailored monitoring and intervention. Conclusion: Elevated TC, HDL-C, LDL-C, ApoA1, and ApoB levels independently predict progression to arthroplasty and shorten time to surgery, providing an evidence base for lipid-targeted strategies in OA management.

  • Open Access

    Two-step consensus clustering approach to immune cell infiltration: An integrated exploration and validation of prognostic and immune implications in sarcomas

    by Ao-Yu Li, Jie Bu, Hui-Ni Xiao, Zi-Yue Zhao, Jia-Lin Zhang, Bin Yu, Hui Li, Jin-Ping Li, Tao Xiao


  • Open Access

    Sarcopenia as a predictor of nutritional status and comorbidities: a cross-sectional and mendelian randomization study

    by Chao Liu, Guanyi Chen, Yu Xia, Pingxiao Wang, Ziyue Zhao, JiaLin Zhang, Tao Xiao, Hui Li

    With the advancement of world population aging, age-related sarcopenia (SP) imposes enormous clinical burden on hospital. Clinical research of SP in non-geriatric wards has not been appreciated, necessitating further investigation. However, observational studies are susceptible to confounders. Mendelian randomization (MR) can effectively mitigate bias to assess causality. To investigate the correlation between SP and comorbidities in orthopedic wards, and subsequently infer the causality, providing a theoretical basis for developing strategies in SP prevention and treatment. Logistic regression models were employed to assess the correlation between SP and comorbidities. The MR analysis was mainly conducted with inverse variance weighted, utilizing data extracted from the UK and FinnGen biobank (Round 9). In the cross-sectional analysis, SP exhibited significant associations with malnutrition (P = 0.013) and some comorbidities, including osteoporosis (P = 0.014), body mass index (BMI) (P = 0.021), Charlson Comorbidity Index (CCI) (P = 0.006). The MR result also provided supporting evidence for the causality between SP and hypertension, osteoporosis and BMI. These results also withstood multiple sensitivity analyses assessing the validity of MR assumptions. The result indicated a significant association between SP and BMI, CCI, malnutrition, and osteoporosis. We highlighted that SP and comorbidities deserved more attention in non-geriatric wards, urging further comprehensive investigation.


  • Open Access

    Effects of walking on epigenetic age acceleration: a Mendelian randomization study

    by Guan-Yi Chen, Chao Liu, Yu Xia, Ping-Xiao Wang, Zi-Yue Zhao, Ao-Yu Li, Chu-Qiao Zhou, Cheng Xiang, Jia-Lin Zhang, Yi Zeng, et al.

    Introduction: Walking stands as the most prevalent physical activity in the daily lives of individuals and is closely associated with physical functioning and the aging process. Nonetheless, the precise cause-and-effect connection between walking and aging remains unexplored. The epigenetic clock emerges as the most promising biological indicator of aging, capable of mirroring the biological age of the human body and facilitating an investigation into the association between walking and aging. Our primary objective is to investigate the causal impact of walking with epigenetic age acceleration (EAA). Methods: We conducted a two-sample two-way Mendelian randomization (MR) study to investigate the causal relationship between walking and EAA. Walking and Leisure sedentary behavior data were sourced from UK Biobank, while EAA data were gathered from a total of 28 cohorts. The MR analysis was carried out using several methods, including the inverse variance weighted (IVW), weighted median, MR-Egger, and robust adjusted profile score (RAPS). To ensure the robustness of our findings, we conducted sensitivity analyses, which involved the MR-Egger intercept test, Cochran’s Q test, and MR-PRESSO, to account for and mitigate potential pleiotropy. Results: The IVW MR results indicate a significant impact of usual walking pace on GrimAge (BETA = − 1.84, 95% CI (− 2.94, − 0.75)), PhenoAge (BETA = − 1.57, 95% CI (− 3.05, − 0.08)), Horvath (BETA = − 1.09 (− 2.14, − 0.04)), and Hannum (BETA = − 1.63, 95% CI (− 2.70, − 0.56)). Usual walking pace is significantly associated with a delay in epigenetic aging acceleration (EAA) (P < 0.05). Moreover, the direction of effect predicted by the gene remained consistent across RAPS outcomes and sensitivity MR analyses. There is a lack of robust causal relationships between other walking conditions, such as walking duration and walking frequency, on EAA (P > 0.05). Conclusion: Our evidence demonstrates that a higher usual walking pace is associated with a deceleration of the acceleration of all four classical epigenetic clocks acceleration.


  • Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation

    by Ao-Yu Li, Hui-Ni Xiao, Zi-Yue Zhao, Cheng Xiang, Zhuo-Yuan Chen, Ping-Xiao Wang, Yu Xia, Bin Yu, Hui Li, Tao Xiao

    Objectives This study aims to develop and validate a prognostic signature based on 7-methylguanosine-related (M7G-related) miRNAs for predicting prognosis and immune implications in breast invasive carcinoma (BRCA). Materials and methods M7G-related miRNA data of BRCA were obtained from The Cancer Genome Atlas (TCGA). Least absolute shrinkage and selection operator (LASSO)-penalized, univariate, and multivariate Cox regression analyses were used to construct the prognostic signature. Furthermore, the predictive validity was verified using Kaplan–Meier (KM) survival risk and receiver operating characteristic (ROC) plots. Internal random sampling verification was used to simplify and validate the signature. RT-qPCR was used to quantify the expression level of transcriptional profiles. The independent prognostic role of the risk score was validated using univariate and multivariate regression. Single-sample Gene Set Enrichment Analysis (ssGSEA) was used for functional and immune enrichment analysis. Results A total of 18 M7G-related miRNAs were identified to construct the prognostic signature in BRCA. The low-risk group exhibited significantly higher overall survival than the high-risk group in the KM survival plot (P < 0.001). The area under the curve (AUC) for 1-, 3-, and 5-year survivals in the ROC curve were 0.737, 0.724, and 0.702, respectively. The survival significance in the training and testing cohorts was confirmed by random sampling verification. The most prominent miRNAs in the signature were the miR-7, miR-139, miR-10b, and miR-4728. Furthermore, immune scores for B, mast, and Th1 cells varied between risk groups. Our research demonstrated that CD52 was the most positively correlated gene with immune cells and functions in BRCA. Conclusion Our study presents a comprehensive and systematic analysis of M7G-related miRNAs to construct a prognostic signature in BRCA. The signature demonstrated excellent prognostic validity, with the risk score as an independent prognostic factor. These results provide critical evidence for further investigation of M7G miRNAs and offer new insights for BRCA patients in the context of effective immunotherapy.


  • Open Access

    COVID‐19 and sarcopenia-related traits: a bidirectional Mendelian randomization study

    by Chao Liu, Ningyuan Liu, Yi Zeng, Bo Xiao, Pingxiao Wang, Chuqiao Zhou, Yu Xia, Ziyue Zhao, Tao Xiao, Hui Li

    Background: Emerging evidence suggested that coronavirus disease 2019 (COVID-19) patients were more prone to acute skeletal muscle loss and suffer sequelae, including weakness, arthromyalgia, depression and anxiety. Meanwhile, it was observed that sarcopenia (SP) was associated with susceptibility, hospitalization and severity of COVID-19. However, it is not known whether there is causal relationship between COVID‐19 and SP-related traits. Mendelian randomization (MR) was a valid method for inferring causality.Methods: Data was extracted from the COVID‐19 Host Genetic Initiative and the UK Biobank without sample overlapping. The MR analysis was performed with inverse variance weighted, weighted median, MR-Egger, RAPS and CAUSE, MR-APSS. Sensitivity analysis was conducted with MR-Egger intercept test, Cochran’s Q test, MR-PRESSO to eliminate pleiotropy.Results: There was insufficient result in the MR-APSS method to support a direct causal relationship after the Bonferroni correction. Most other MR results were also nominally consistent with the MR-APSS result.Conclusions: Our study first explored the causal relationship between COVID-19 and SP-related traits, but the result indicated that they may indirectly interact with each other. We highlighted that older people had better absorb enough nutrition and strengthen exercise to directly cope with SP during the COVID-19 pandemic.


  • Open Access

    CD24-associated ceRNA network reveals prognostic biomarkers in breast carcinoma

    by Bin Yu, Ziyue Zhao, Zhuoyuan Chen, Cheng Xiang, Pingxiao Wang, Bo Xiao, Yu Xia, Aoyu Li, Tao Xiao, Hui Li

    Breast cancer is one of the most common cancer types which is described as the leading cause of cancer death in women. After competitive endogenous RNA (ceRNA) hypothesis was proposed, this triple regulatory network has been observed in various cancers, and increasing evidences reveal that ceRNA network plays a significant role in the migration, invasion, proliferation of cancer cells. In the current study, our target is to construct a CD24-associated ceRNA network, and to further identify key prognostic biomarkers in breast cancer. Using the transcriptom profiles from TCGA database, we performed a comprehensive analysis between CD24high tumor samples and CD24low tumor samples, and identified 132 DElncRNAs, 602 DEmRNAs and 26 DEmiRNAs. Through comprehensive analysis, RP1-228H13.5/miR-135a-5p/BEND3 and SIM2 were identified as key CD24-associated biomarkers, which exhibited highly significance with overall survival, immune microenvironment as well as clinical features. To sum up the above, the current study constructed a CD24-associated ceRNA network, and RP1-228H13.5/miR-135a-5p/BEND3 and SIM2 axis worked as a potential therapeutic target and a predictor for BRCA diagnosis and prognosis.


  • Influence of the pKa value on the antioxidant activity of licorice flavonoids under solvent‐mediated effects

    by Yi Hu, Zhuxian Wang, Chunyan Shen, CuiPing Jiang, Zhaoming Zhu, Peiyi Liang, Hui Li, Quanfu Zeng, Yaqi Xue, Yufan Wu, et al.

    Licorice flavonoids (LCFs) have been widely used in food care and medical treatment due to their significant antioxidant activities. However, the molecular mechanism of their antioxidant activity remains unclear. Therefore, network pharmacology, ADMET, density functional theory (DFT), molecular docking, and molecular dynamics (MD) simulation were employed to explore the molecular mechanism of the antioxidant effects of LCF. The network pharmacology and ADMET studies showed that the active molecules of kumatakenin (pKa = 6.18), licoflavonol (pKa = 6.86), and topazolin (pKa = 6.21) in LCF are key antioxidant components and have good biosafety. Molecular docking and MD simulation studies demonstrated that active molecules interacted with amino acid residues in target proteins to form stable protein–ligand complexes and exert their antioxidant effects. DFT studies showed that the antioxidant activity of LCF could be significantly modulated under the solvent‐mediated effect. In addition, based on the derivation of the Henderson–Hasselbalch and van't Hoff formulas, the functional relationships between the reaction‐free energy (ΔG) of LCF and the pH and pKa values were established. The results showed that active molecules with larger pKa values will be more conducive to the improvement of their antioxidant activity under solvent‐mediated effects. In conclusion, this study found that increasing the pKa value of LCF would be an effective strategy to improve their antioxidant activity under the effect of solvent mediation. The pKa value of an LCF will be a direct standard to evaluate its solvent‐mediated antioxidant activity. This study will provide theoretical guidance for the development of natural antioxidants.